Prostate Cancer - Results from #27220

High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: Treatment description and preliminary results - Abstract October 7, 2011

Novel therapies for metastatic castrate-resistant prostate cancer - Abstract October 7, 2011

Examining the influence of social ecological factors on prostate cancer screening in urban African-American men - Abstract October 7, 2011

Men's use of an internet-based decision aid for prostate cancer screening - Abstract October 7, 2011

Stereotactic body radiation therapy for prostate cancer - Abstract October 7, 2011

A descriptive study of functions, symptoms, and perceived health state after radiotherapy for prostate cancer - Abstract October 7, 2011

Subcapsular orchiectomy in the primary therapy of patients with bone metastasis in advanced prostate cancer: An anachronistic intervention? - Abstract October 7, 2011

MRI of localized prostate cancer: Coming of age in the PSA era - Abstract October 7, 2011

Editor's Commentary - Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer: A decision analysis October 7, 2011

Editor's Commentary - Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators October 6, 2011

Prostate MRI: Diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours - Abstract October 6, 2011

Surgical, oncologic, and short-term functional outcomes in patients undergoing robot-assisted prostatectomy after previous transurethral resection of the prostate - Abstract October 6, 2011

Cancer Care Ontario Guidelines for radical prostatectomy: Striving for continuous quality improvement in community practice - Abstract October 6, 2011

Serum total and HDL cholesterol and risk of prostate cancer - Abstract October 6, 2011

Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: A meta-analysis of four randomized controlled trials - Abstract October 6, 2011

Anatomical grades of nerve sparing: A risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP) - Abstract October 6, 2011

Smoking and prostate cancer survival and recurrence - Abstract October 6, 2011

Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer - Abstract October 5, 2011

Survival after incidental prostate cancer diagnosis at transurethral resection of prostate: 10-Year outcomes - Abstract October 5, 2011

Sexual adjustment to androgen deprivation therapy: Struggles and strategies - Abstract October 5, 2011

Page 1362 of 1447